<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>The evidence suggesting GLP-1s can curb drug and alcohol cravings — Live Feed</title><link>https://www.live-feeds.com/feed/the-evidence-suggesting-glp-1s-can-curb-drug-and-alcohol-cravings</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/the-evidence-suggesting-glp-1s-can-curb-drug-and-alcohol-cravings/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>GLP-1 Drugs Show Potential in Curbing Addiction Cravings</title><link>https://www.live-feeds.com/feed/the-evidence-suggesting-glp-1s-can-curb-drug-and-alcohol-cravings</link><guid isPermaLink="false">https://www.live-feeds.com/feed/the-evidence-suggesting-glp-1s-can-curb-drug-and-alcohol-cravings#u113839</guid><pubDate>Sat, 10 Oct 2026 11:15:54 +0000</pubDate><description>A growing body of evidence indicates that GLP-1 medications, widely used for diabetes and weight loss, can effectively curb human desire for drugs and alcohol. Researchers are testing these treatments to address the national addiction crisis. Among the developments, a major clinical trial demonstrates that pairing a weekly GLP-1 shot with cognitive behavioral therapy cuts heavy drinking days significantly. Additional findings show that GLP-1 receptor agonists present promise regarding opioid overdose among veterans, though experts emphasize that more research is needed to fully understand thei</description></item>
</channel></rss>